Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intensive Blood Pressure and LDL Lowering for Better Survival and Cardiovascular Outcome in Diabetic Patients With Coronary Artery Disease: Randomized Controlled Trial

NCT01422421 is registered in ClinicalTrials.gov with Takeshi Morimoto as lead sponsor.

NCT NCT01422421
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01422421 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intensive Blood Pressure and LDL Lowering for Better Survival and Cardiovascular Outcome in Diabetic Patients With Coronary Artery Disease: Randomized Controlled Trial
Lead sponsor
Takeshi Morimoto
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2011
Completion date
December 31, 2023
Enrollment
798 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery disease, dyslipidemia, hypertension, type 2 diabetes